By submitting, you consent that you are at least 18 years of age and to receive information about MPR's or APMG entities' programs and offerings. The personally identifying information you provide will not be sold, shared, or used for purposes other than to communicate with you about MPR, APMG entities, and its sponsors. You may opt-out at any time clicking the unsubscribe link at the bottom of any email communication. View our Privacy Policy.
Johnson & Johnson's long-awaited vaccine appears to protect against COVID-19 with just one shot — not as strong as some two-shot rivals but still potentially helpful for a world in dire need of more doses.
The newest numbers come a day after Gov. Tim Walz expressed hope that most Minnesotans who are not in a priority group for a COVID-19 vaccine dose could be vaccinated in March or April.
Minnesota’s race to vaccinate educators and child care workers is now in its second week. The launch has successfully gotten shots into the arms of thousands of people, but it’s just a fraction of the state’s teaching force. And it’s not been without its share of mishap.
A disproportionately small number of Black and Hispanic Americans have gotten vaccinated so far. Samantha Artiga of the Kaiser Family Foundation discusses barriers to access and what needs to be done.
Novavax says its COVID-19 vaccine appears 89 percent effective, based on early findings from a British study. The shot also seems to work against new mutated versions of the virus circulating in that country and South Africa, though not as well.
The Republican-controlled Wisconsin Assembly has backed off on voting to repeal Democratic Gov. Tony Evers’ mask mandate. The retreat Thursday came in the face of broad criticism from the state’s health, school and business leaders and out concern the move would jeopardize more than $49 million in federal food assistance.
A new coronavirus variant identified in South Africa has been found in the United States for the first time, with two cases diagnosed in South Carolina, state health officials said Thursday.
With demand for COVID-19 vaccines outpacing the world's supplies, a frustrated public and policymakers want to know: How can we get a lot more, fast? But scaling up vaccine production is a slow and steady process. As one expert explains, it's not simply adding more water to the soup.